A late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent, drug-conjugation technology that creates drug products designed to kill tumors and increase immune system recognition of cancers, announces it has been named a winner of the 2026 Pinnacle Awards for Healthcare for its intratumoral injection platform and lead drug candidate INT230-6.
The Company was selected a Platinum award winner in the Innovator in Biotech Solutions Category. INT230-6, Intensity’s lead proprietary investigational product candidate, is designed for direct intratumoral injection. The drug consists of two proven, potent anti-cancer agents, cisplatin and vinblastine sulfate, and a diffusion and cell penetration enhancer molecule (“SHAO”) that non-covalently conjugates to the two payload drugs, facilitating the dispersion of potent cytotoxic drugs throughout tumors and allowing the active agents to diffuse into cancer cells. INT230-6 is being developed in combination with standard-of-care therapies to improve the durability of response across multiple solid tumor indications.
“The recognition from the Pinnacle Award is a testament to Intensity’s commitment to changing the future of cancer care,” said Intensity Therapeutics Co-Founder and CEO Lewis H. Bender. “INT230-6 represents a new, unique methodology for cancer cell death that holds the potential to shift the cancer treatment from a short-term death sentence to chronic diseases, even for malignancies that are unresponsive to immunotherapy.”
The Pinnacle Awards is an esteemed annual awards program dedicated to recognizing and celebrating outstanding achievements across various industries. Its mission is to honor companies, products, and individuals that have demonstrated exceptional innovation, creativity, and impact in their fields. Each year, nominees are evaluated by industry experts, media professionals, and consultants who ensure that only the most deserving candidates receive recognition.
Read Also: Marshall Health Network partners with Notable to launch online scheduling and registration platform
